🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hepatocellular carcinoma (HCC) patients is a common disease in the East Asi...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-07-08
Trial ID
NCT04424043
Treatments Being Tested
The purpose of this study is to determine whether TACE combined endovascula...
Status
Withdrawn
Location
Department of Interventional Radiology, Zhongshan Hospital, Fudan University
Start Date
2014-05
Trial ID
NCT02149771
Treatments Being Tested
Toripalimab and bevacizumab (T-B) was approve for unresectable hepatocellul...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-01-23
Trial ID
NCT07380633
Treatments Being Tested
The purpose of this study is to investigate whether TAC plus FOLFOX4 or TAC...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2008-01
Trial ID
NCT00868569
Treatments Being Tested
Atezolizumab and bevacizumab was approve for advanced unresectable hepatoce...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2023-03-09
Trial ID
NCT05751343
Treatments Being Tested
Hepatocellular carcinoma (HCC) patients is a common disease in the East Asi...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-12-16
Trial ID
NCT04181931
Treatments Being Tested
The purpose of this study is to determine if TACE plus Recombinant Human Ad...
Status
Unknown
Location
Cancer Center Sun Yat-sen University
Start Date
2013-01
Trial ID
NCT01869088
Treatments Being Tested
Hepatocellular carcinoma (HCC) patients is a common disease in the East Asi...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2021-02-20
Trial ID
NCT04777942
Treatments Being Tested